Peter Toth
Preventive cardiology leader and past president of the American Society for Preventive Cardiology, serving as director of preventive cardiology and providing expert commentary on PCSK9 inhibitors, LDL lowering safety, and clinical implementation.
Best podcasts with Peter Toth
Ranked by the Snipd community
5 snips
Feb 15, 2022 • 23min
Recent Clinical Advances in Reducing Risk for Dyslipidemia
Peter Toth, preventive cardiology leader with PCSK9 and LDL expertise, and Erin Michos, cardiovascular prevention clinician-scientist, discuss nonstatin therapies and practical implementation. They cover PCSK9 inhibitors vs apheresis, inclisiran and bempedoic acid, managing triglycerides and lipoprotein(a). They also tackle access barriers and safety of very low LDL levels.
